QR-Code

Activity of difloxacin (A-56619) and A-56620 against clinical anaerobic bacteria in vitro.

We determined the MICs of difloxacin (A-56619) and A-56620 against anaerobic bacteria and assessed the effects of alterations in pH, size of inoculum, addition of human serum, and repeated exposure to subinhibitory levels of antibiotics. We tested for synergism of these drugs with cefoxitin against...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Veröffentlicht in:Antimicrob Agents Chemother
Hauptverfasser: Bansal, M B, Thadepalli, H
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology (ASM) 1987
Schlagworte:
Online-Zugang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174790/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3606066/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.4.619
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!